MEK and the inhibitors: from bench to bedside

标题

作者

关键词

Melanoma, Docetaxel, Papillary Thyroid Cancer, Malignant Mesothelioma, Vemurafenib

出版物

Volume 6, Issue 1, Pages 27

出版商

Springer Nature

发表日期

2013-04-12

DOI

10.1186/1756-8722-6-27

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now